Self-monitoring of oral anticoagulation: systematic review and meta-analysis of individual patient data

BACKGROUND Uptake of self-testing and self-management of oral anticoagulation [corrected] has remained inconsistent, despite good evidence of their effectiveness. To clarify the value of self-monitoring of oral anticoagulation, we did a meta-analysis of individual patient data addressing several important gaps in the evidence, including an estimate of the effect on time to death, first major haemorrhage, and thromboembolism. METHODS We searched Ovid versions of Embase (1980-2009) and Medline (1966-2009), limiting searches to randomised trials with a maximally sensitive strategy. We approached all authors of included trials and requested individual patient data: primary outcomes were time to death, first major haemorrhage, and first thromboembolic event. We did prespecified subgroup analyses according to age, type of control-group care (anticoagulation-clinic care vs primary care), self-testing alone versus self-management, and sex. We analysed patients with mechanical heart valves or atrial fibrillation separately. We used a random-effect model method to calculate pooled hazard ratios and did tests for interaction and heterogeneity, and calculated a time-specific number needed to treat. FINDINGS Of 1357 abstracts, we included 11 trials with data for 6417 participants and 12,800 person-years of follow-up. We reported a significant reduction in thromboembolic events in the self-monitoring group (hazard ratio 0·51; 95% CI 0·31-0·85) but not for major haemorrhagic events (0·88, 0·74-1·06) or death (0·82, 0·62-1·09). Participants younger than 55 years showed a striking reduction in thrombotic events (hazard ratio 0·33, 95% CI 0·17-0·66), as did participants with mechanical heart valve (0·52, 0·35-0·77). Analysis of major outcomes in the very elderly (age ≥85 years, n=99) showed no significant adverse effects of the intervention for all outcomes. INTERPRETATION Our analysis showed that self-monitoring and self-management of oral coagulation is a safe option for suitable patients of all ages. Patients should also be offered the option to self-manage their disease with suitable health-care support as back-up. FUNDING UK National Institute for Health Research (NIHR) Technology Assessment Programme, UK NIHR National School for Primary Care Research.

[1]  J Michael Hasenkam,et al.  Self-management of oral anticoagulant therapy: a systematic review and meta-analysis. , 2007, International journal of cardiology.

[2]  T. Wilt,et al.  Meta-analysis: Effect of Patient Self-testing and Self-management of Long-Term Anticoagulation on Major Clinical Outcomes , 2011, Annals of Internal Medicine.

[3]  D. Matchar,et al.  An evaluation of patient self-testing competency of prothrombin time for managing anticoagulation: pre-randomization results of VA Cooperative Study #481–The Home INR Study (THINRS) , 2010, Journal of Thrombosis and Thrombolysis.

[4]  R. Collins,et al.  Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins , 2005, The Lancet.

[5]  F. Rosendaal,et al.  Comparison of the quality of oral anticoagulant therapy through patient self-management and management by specialized anticoagulation clinics in the Netherlands: a randomized clinical trial. , 2003, Archives of internal medicine.

[6]  D G Altman,et al.  Calculating the number needed to treat for trials where the outcome is time to an event , 1999, BMJ.

[7]  I. Rakovac,et al.  Self-management of oral anticoagulation reduces major outcomes in the elderly , 2008, Thrombosis and Haemostasis.

[8]  M. Sydes,et al.  Practical methods for incorporating summary time-to-event data into meta-analysis , 2007, Trials.

[9]  R. Perera,et al.  Self-monitoring of oral anticoagulation: a systematic review and meta-analysis , 2006, The Lancet.

[10]  D. Fitzmaurice,et al.  An evidence‐based review and guidelines for patient self‐testing and management of oral anticoagulation , 2005, British journal of haematology.

[11]  H. Cohen,et al.  A randomised controlled trial of patient self management of oral anticoagulation compared with patient self-testing. , 2005 .

[12]  O. Wagner,et al.  INR-Selbstmanagement nach mechanischem Herzklappenersatz: ESCAT (Early Self-Controlled Anticoagulation Trial) , 2013, Zeitschrift für Kardiologie.

[13]  D. Fitzmaurice,et al.  Self-monitoring and self-management of oral anticoagulation. , 2010, The Cochrane database of systematic reviews.

[14]  Stephane Heritier,et al.  Monitoring Cholesterol Levels: Measurement Error or True Change? , 2008, Annals of Internal Medicine.

[15]  D Bergqvist,et al.  Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients , 2010, Journal of thrombosis and haemostasis : JTH.

[16]  D. Altman,et al.  Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.

[17]  F. Kamali,et al.  The value of education and self‐monitoring in the management of warfarin therapy in older patients with unstable control of anticoagulation , 2004, British journal of haematology.

[18]  P. Sawicki,et al.  A structured teaching and self-management program for patients receiving oral anticoagulation: a randomized controlled trial. Working Group for the Study of Patient Self-Management of Oral Anticoagulation. , 1999, JAMA.

[19]  Steve McDonald,et al.  Development of the Cochrane Collaboration’s Central Register of Controlled Clinical Trials , 2002, Evaluation & the health professions.

[20]  Agnieszka Narkun.  [Summary of the article: Matchar B, Jacobson DB, Dolor R et al. Effect of home testing of international normalized ratio on clinical events. N Engl J Med, 2010; 363: 1608-1620]. , 2011, Kardiologia polska.

[21]  G. Lip,et al.  Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial , 2007, The Lancet.

[22]  P. Lavori,et al.  Effect of home testing of international normalized ratio on clinical events. , 2010, The New England journal of medicine.

[23]  Leon Poller,et al.  European Concerted Action on Anticoagulation , 2002, Thrombosis and Haemostasis.

[24]  D. Fitzmaurice,et al.  A randomised controlled trial of patient self management of oral anticoagulation treatment compared with primary care management , 2002, Journal of clinical pathology.

[25]  G. Lip,et al.  Management of atrial fibrillation: the NICE guidelines , 2007, International journal of clinical practice.

[26]  Colin F. Coor.  Self management of oral anticoagulation: Randomised trial , 2006 .

[27]  L. Lynd,et al.  Cost-effectiveness of self-managed versus physician-managed oral anticoagulation therapy , 2006, Canadian Medical Association Journal.

[28]  L. Stewart,et al.  SCHARP Survival Curve and Hazard Ratio Program , 1998 .

[29]  R. Körfer,et al.  [INR self-management after mechanical heart valve replacement: ESCAT (Early Self-Controlled Anticoagulation Trial)]. , 2001, Zeitschrift fur Kardiologie.

[30]  A. Forster,et al.  Effect of study setting on anticoagulation control: a systematic review and metaregression. , 2006, Chest.

[31]  F R Rosendaal,et al.  A Method to Determine the Optimal Intensity of Oral Anticoagulant Therapy , 1993, Thrombosis and Haemostasis.

[32]  X. Bonfill,et al.  Comparing Self-Management of Oral Anticoagulant Therapy with Clinic Management , 2005, Annals of Internal Medicine.

[33]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[34]  J. Jespersen,et al.  European concerted action on anticoagulation. Quality assessment of the CoaguChek Mini and TAS PT-NC point-of-care whole-blood prothrombin time monitors. , 2004, Clinical chemistry.

[35]  A. Berghold,et al.  Systematic review of studies of self-management of oral anticoagulation , 2004, Thrombosis and Haemostasis.

[36]  M Alan Brookhart,et al.  Primary prevention of cardiovascular diseases with statin therapy: a meta-analysis of randomized controlled trials. , 2006, Archives of internal medicine.

[37]  H. O'kane,et al.  Self-managed anticoagulation: results from a two-year prospective randomized trial with heart valve patients. , 2001, The Annals of thoracic surgery.

[38]  D. Horstkotte,et al.  Optimal Frequency of Patient Monitoring and Intensity of Oral Anticoagulation Therapy in Valvular Heart Disease , 2004, Journal of Thrombosis and Thrombolysis.

[39]  S. Kuhle,et al.  EMPoWarMENT: Edmonton pediatric warfarin self-management pilot study in children with primarily cardiac disease. , 2010, Thrombosis research.

[40]  J. Lusson,et al.  Comparison of INR stability between self-monitoring and standard laboratory method: preliminary results of a prospective study in 67 mechanical heart valve patients. , 2008, Archives of cardiovascular diseases.

[41]  H. Völler,et al.  Guidelines for implementation of patient self-testing and patient self-management of oral anticoagulation. International consensus guidelines prepared by International Self-Monitoring Association for Oral Anticoagulation. , 2005, International journal of cardiology.

[42]  M. Bramkamp,et al.  Pharmacoeconomics of anticoagulation therapy for stroke prevention in atrial fibrillation: a review , 2006, Journal of thrombosis and haemostasis : JTH.

[43]  C. Stevens,et al.  Clinical effectiveness and cost-effectiveness of different models of managing long-term oral anticoagulation therapy: a systematic review and economic modelling. , 2007, Health technology assessment.

[44]  H. Sørensen,et al.  Self-management versus conventional management of oral anticoagulant therapy: A randomized, controlled trial. , 2006, European journal of internal medicine.

[45]  D. Fitzmaurice,et al.  Self-monitoring and self-management of oral anticoagulation (Review) , 2010 .

[46]  S. Schulman,et al.  Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non‐surgical patients , 2005, Journal of thrombosis and haemostasis : JTH.

[47]  M. Prins,et al.  Oral anticoagulation self-management and management by a specialist anticoagulation clinic: a randomised cross-over comparison , 2000, The Lancet.

[48]  A. Fung,et al.  A randomized trial of patient self-managed versus physician-managed oral anticoagulation. , 2004, The Canadian journal of cardiology.

[49]  A. V. Straten,et al.  Self-management program improves anticoagulation control and quality of life: a prospective randomized study , 2009 .

[50]  S A McCurdy,et al.  Home prothrombin time monitoring after the initiation of warfarin therapy. A randomized, prospective study. , 1989, Annals of internal medicine.

[51]  G. Lip,et al.  Management of atrial fi brillation , 2007 .

[52]  R. Beyth,et al.  A Multicomponent Intervention To Prevent Major Bleeding Complications in Older Patients Receiving Warfarin , 2000, Annals of Internal Medicine.

[53]  D. J. Glatz,et al.  Self-Management of oral Anticoagulation in nonvalvular Atrial Fibrillation (SMAAF study) , 2005, Zeitschrift für Kardiologie.